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DATA AND DEVICES
Outcomes in open repair of the thoracic and
thoracoabdominal aorta
Charles Acher, MD,a and Martha Wynn, MD,b Madison, WiscThere has been a significant decrease in mortality and
paraplegia risk during the last 25 years in the treatment of
thoracic and thoracoabdominal aortic disease (Fig 1). The
primary factors in this improvement have been the use of
cerebrospinal fluid drainage and moderate to profound
hypothermia, combined with optimizing arterial perfusion
pressure and cardiac function and the use of neurochemical
protection. Effective application of these critical concepts
has resulted in a 75% to 80% reduction in paraplegia and a
50% reduction in mortality in most single-center reports
where surgery is supported by a dedicated anesthesia and
surgical team using treatment protocols that optimize these
critical factors.1-4 However, there is still considerable vari-
ation in mortality and paraplegia rates in clinical reports,
with little understanding of the causes of this variation in
outcomes (Table I).
This report will attempt to explain this variation and
identify some of the factors associated with mortality, para-
plegia, renal failure, and long-term functional outcome. To
accomplish this, a paraplegia risk model based on the extent
of aortic replacement (Crawford classification) and clinical
presentation (acute and dissection),5 and a mortality risk
model to compare risk from published reports are used to
analyze results from clinical reports. The mortality risk
model is based on the proportion of acute patients and the
predicted number of paraplegias multiplied by a risk coef-
ficient of 0.3 (the coefficient with the highest R2 value and
approximates the mean acute and paraplegia associated
mortality). This mortality model accounts for 76% of the
variation between reports (Fig 2).
The data for this analysis come from our own prospec-
tively maintained database, which now includes 771 pa-
tients, and a database of approximately 100 publications
From the Departments of Surgerya and Anesthesiology,b University of
Wisconsin.
Competition of interest: none.
Correspondence: Dr Charles W. Acher, University of Wisconsin, Depart-
ment of Anesthesiology, Madison, WI 53792-7375 (e-mail: acher@
surgery.wisc.edu).
The editors and reviewers of this article have no relevant financial relationships
to disclose per the JVS policy that requires reviewers to decline review of any
manuscript for which they may have a competition of interest.
J Vasc Surg 2010;52:3S-9S
0741-5214/$36.00
Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.
doi:10.1016/j.jvs.2010.06.137reporting outcomes in 15,000 patients that we have
maintained during the last 25 years. In our own patients we
have prospectively measured cardiac index as a measure of
cardiac function before, during, and after aortic cross-
clamp and estimated glomerular filtration rate before sur-
gery and up to 60 days after surgery, as well as other
physiologic variables.
MORTALITY
Although mortality rates have improved over time in
single-center reports, repair of these aneurysms is still rec-
ognized as high risk, with elective mortality and paraplegia
rates 20% in reports using national and regional data-
bases.6,7 In the report by Rigberg et al7 from California’s
statewide database, 30-day and 1-year mortality (elective
and ruptured) was stratified by age, with an elective mor-
tality of 19% at 30 days and 31% at 1 year, varying at 1 year
from 18% for ages 50 to 59 years to 40% for 80 to 89 years.
Ruptured mortality was 48% at 30 days and 62% at 1 year,
with significant increases with age.7 The Cowan et al6
report looked nationally at elective mortality, which ranges
from 15% in high-volume hospitals (5-31 per year) to 27%
in low-volume hospitals (1-3 per year). Both reports con-
cluded that higher volume was associated with lower mor-
tality, whether by hospital or surgeon.
The mean mortality rate in single-center reports is
12.5% (range, 0% to 44%). Adjusted for acuity and paraple-
gia, mortality observed/expected (O/E) ratios are a mean
of 0.87 (range, 0 to 9.8). Since 1997, these mortality
numbers have declined significantly to a mean mortality of
8.84% and mortality O/E ratio of 0.37 (Table I). Consis-
tently, the most important factors for mortality in these
reports are age, acuity, paraplegia, and decreased renal
function.8-12
At the University of Wisconsin (UW), mortality for
elective procedures is 3.1% and is 17.8% for acute patients,
defined as rupture, contained rupture, acute dissection,
mycotic aortitis, trauma, and acute plaque hemorrhage. In
a multivariate model, the most important factors for oper-
ative mortality in our experience have been age, acute
presentation, postoperative paraplegia, and poor renal
function (serum creatinine 2 mg/dL; Table I). Factors
significant on univariate analysis, such as transfusion vol-
ume, aortic occlusion time, cardiac index, and extent of
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iate model.
Advanced age is a marker for comorbid conditions such
as cardiac disease, chronic obstructive pulmonary disease,
renal insufficiency, and advanced atherosclerosis that in-
crease with age and are associated with higher treatment
risk.13-16 Pulmonary function is a significant factor for
complications as well as short-term and long-term survi-
val.17 The importance of age-related factors is highlighted
by the stark difference in mortality risk of 0.7% (1 of 142
patients; no elective 30-day deaths) in our patients aged
60 years and 8.9% (elective 3.4%, acute 20.9%) in patients
aged 60 years, even though there were more acute pre-
sentations in the younger patients (45% vs 31%).
Surprisingly, previous coronary artery bypass grafting
(CABG) or percutaneous transluminal coronary angio-
plasty (PTCA) patients did not have increasedmortality risk
in our experience (6.4% with CABG or PTCA and 8.9%
without, P  .3283). However, it is clear that cardiac
function declines with age (Fig 3, A) and decreased cardiac
reserve is associated with increased mortality risk. Car-
diac function, as we have previously shown, is a risk factor for
paraplegia, which is a significant factor in our multivariate
model for mortality (Fig 3, B).18 Renal function also de-
clines significantly with age (Fig 4) and is independently
significant for death, as is age (Table II).
The increase in mortality risk with age is apparent when
comparing elective and acute mortality risk by decade (Ta-
ble III). Three factors define the highest risk group of
patients: those aged80, with creatinine2 mg/dL, who
present acutely. Our 30-day mortality rate was 75% in this
group. Of these, 40% died of cardiac causes, 26% of pulmo-
nary causes, and 20% of multiorgan system failure, but half
of these began with pneumonia. It is also clear from this
analysis that age-related comorbidities help define that
elusive quality of vitality that may improve survival proba-
Fig 1. Using two factors we found to be important for mortality,
paraplegia, and acuity, we estimated mortality risk in different
series (Table I, Fig. 2). Combining calculated paraplegia and
mortality into a ratio with actual paraplegia and mortality we get
morbidity observed/expected (O/E) ratio to compare between
series and over time. There has been a significant decline in overall
morbidity in the last 25 years in single-center reports.bility.PARAPLEGIA
The decline in paraplegia risk during the last 25 years
has been significant, with O/E ratios declining from an
average of 1 to 0.25 or less inmost clinical reports in the last
decade (Table I). For instance, the paraplegia rate at Baylor
in Houston has declined from 16% (O/E 1.0) during the
Crawford era to 3.8% (O/E 0.22) in the Coselli era.19,20
Similar declines are reported by other authors when com-
paring results from reports in the early 1990s with the last
decade21-23 (Table I). This decline is the result of the
clinical introduction of the experimentally validated inter-
ventions of spinal fluid drainage (SFD) and hypothermia,
along with increasing arterial perfusion pressure and im-
proving neurochemical protection using steroids, nalox-
one, and barbiturates.4,24 Adequate perfusion pressure and
the transition from normothermic to hypothermic perfu-
sion when using assisted circulation have also been identi-
fied by several authors as important strategies in preventing
paraplegia.2,25,26
Since the introduction of these strategies in the mid-
1980s, the paralysis rate at UW declined from 25% (O/E
1.04) to 3.3% (O/E 0.18) and has been quite stable since
1990 when we first reported our results.4,27 In our experi-
ence, the most important factors for paraplegia in multivar-
iate modeling are acuity, extent of aortic replacement,
cardiac index, and the spinal cord protection protocol of
SFD, hypothermia, steroids, and naloxone (SFDN; Table
IV). A lower cardiac index after unclamping the aorta,
indicating reduced cardiac reserve, was associated with a
greater risk of paralysis (Fig 5).
Although age is a significant univariate factor, it is
trumped by cardiac index in multivariate modeling, unlike
mortality risk where the opposite is true. The implication of
this is that a stronger pump is important for collateral
perfusion and prevails regardless of age. Mean arterial pres-
sure, age, renal function, and aortic occlusion timewere not
as important.
Core temperature was not a significant factor, but we
aggressively cool patients to34°C before cross-clamping,
and the core temperature declines an additional 2° after
cold renal perfusion solution is infused into each renal
artery for renal preservation. Intercostal reimplantation
does not appear to be a major factor in paraplegia risk but
may be important in high-risk Crawford type 2 and dissec-
tion patients to avoid delayed paraplegia associated with
adverse clinical events such sepsis, myocardial infarction,
bleeding, or hypotension from other causes.26,27
What is clear about prevention of paralysis is the varia-
tion in results within repair techniques: centers with dedi-
cated treatment teams using protocols that aggressively
manage spinal fluid pressure, hypothermia, cardiac func-
tion, and arterial perfusion pressure have better results
(Fig 6).
RENAL FAILURE
Short-term and long-term dialysis have been significant
risks in thoracoabdominal aortic aneurysm repair, with
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generate observed/expected (O/E) ratios to compare techniques of repair and protective adjuncts. O/E Morb is
observed combined mortality and paraplegia divided by estimated mortality and paraplegia
Year Series Technique C1 C2 C3 C4 TA
Deficit
O/E
Pts
(No.)
Def
(%)
Mort
(%)
Acute
(%)
O/E
Mort
O/E
Morb
1987 Kazui AC 14 81 1.32 95 2.11 14.7 10.5 3.29 2.774
1988 Cunningham AC 5 2 23 4.42 30 16.67 20.0 3.3 7.61 5.735
1988 Vaccaro XCL 3 9 8 8 1.20 28 17.86 25.0 25.0 1.70 1.448
1988 Mayo XCL 15 20 20 46 0.65 101 4.95 14.9 1.0 4.68 1.839
1988 Davidson EPIDC 2 2 3 1 0.00 8 0.00 0.0 12.5 0.00 0.000
1989 Keifer AC 3 10 18 3 11 1.47 45 20.00 4.4 2.2 0.76 1.257
1989 Svensson AC 3 7 4.46 10 50.00 20.0 10.0 2.55 3.676
1989 Svensson XCL 1 3 1 4 9.76 9 44.44 44.4 0.0 26.37 14.242
1989 Svensson XCLSFD 1 2 3 4 1.45 10 10.00 10.0 0.0 3.92 2.116
1989 Pokela AC 3 3 11 0.41 17 5.88 5.9 29.4 0.36 0.384
1989 Cambria XCL 12 8 20 15 0.61 55 7.27 34.5 18.2 3.09 1.805
1989 Murray AC 15 4 6 23 0.69 48 8.33 12.5 6.3 1.84 1.099
1989 Murray XCLSFD 8 14 17 11 0.63 50 8.00 12.0 6.0 1.74 1.025
1990 Acher-Wynn XCL 4 8 5 3 4 1.03 24 25.00 8.3 37.5 0.37 0.818
1990 Acher-Wynn XCLSFDN 5 8 5 3 2 0.17 23 4.35 8.7 47.8 0.32 0.246
1990 de Mol AC 3 8 3 0.85 14 21.43 21.4 0.0 2.28 1.234
1990 Schmidt XCL 2 13 22 3 0.49 40 10.00 12.5 42.5 0.54 0.513
1990 Crawford XCL 239 293 261 269 0.98 1062 13.18 10.0 4.7 1.48 1.146
1991 Williams AC 15 14 11 1.46 40 25.00 22.5 2.5 3.10 1.948
1991 Crawford AC 59 85 36 30 1.14 210 20.00 2.9 4.8 0.35 0.887
1991 Lord XCL 12 7 1.33 19 21.05 31.6 5.3 4.05 2.232
1991 Fox XCL 24 27 1.87 51 13.73 27.5 15.7 3.22 2.598
1992 Hollier XCL 22 16 23 47 0.71 108 5.56 7.4 1.9 2.06 1.132
1992 Hollier XCLSFD 7 13 16 6 0.00 42 0.00 16.7 2.4 3.31 1.024
1992 Cox XCL 10 37 40 42 1.01 129 19.38 34.9 41.9 1.54 1.299
1992 Golden XCL 5 9 12 31 2.10 57 17.54 17.5 8.8 2.77 2.385
1993 Williams ACSFD 6 7 0.21 13 7.69 0.0 7.7 0.00 0.144
1993 Crawford XCL 378 442 343 346 1.00 1509 15.51 8.2 6.6 0.99 0.996
1993 Najafi AC 5 3 23 0.52 31 6.45 6.5 9.7 0.79 0.629
1994 Safi ACSFD 14 31 0.28 45 8.89 4.4 6.7 0.31 0.289
1994 Safi AC 73 39 1.26 112 27.68 9.8 5.4 0.97 1.169
1994 Frank ACSFD 3 9 3 1 4 0.00 20 0.00 10.0 5.0 1.33 0.438
1994 Acher XCLSFDN 9 19 6 15 12 0.14 61 3.28 3.3 41.0 0.14 0.141
1994 Keiffer HCA 3 4 1 4 0.27 12 8.33 33.3 8.3 2.31 0.922
1994 Mayo XCL 45 23 68 70 0.92 206 9.22 21.8 14.6 2.40 1.625
1994 Borst AC 21 111 1.35 132 4.55 9.8 10.6 1.90 1.683
1994 Svenson-Coselli AC 44 54 1.31 98 31.63 4.1 1.0 0.44 1.066
1994 Janusz AC 17 3 20 8 0.34 48 4.17 14.6 20.8 1.19 0.759
1994 Coselli XCL 137 95 73 67 0.34 372 6.45 5.4 14.5 0.44 0.379
1994 Galla AC 5 5 16 0.95 26 11.54 15.4 11.5 1.76 1.287
1995 Safi ACSFD 31 63 0.33 94 8.51 9.6 2.1 0.92 0.497
1995 Safi AC 25 17 0.90 42 19.05 14.3 9.5 1.26 1.024
1995 Gilling-Smith XCLSFD 20 29 18 63 0.56 130 7.69 27.7 15.4 2.58 1.453
1995 Shiiya AC 3 6 3 9 1.18 21 23.81 4.8 0.0 0.64 1.033
1995 Kouchoukos HCA 13 13 6 19 0.38 51 5.88 9.8 0.0 1.71 0.740
1998 Kouchoukos HCA 21 21 7 47 0.25 96 3.13 5.2 0.0 1.11 0.482
1995 Comerata ACSFD 4 3 5 3 0.36 15 6.67 6.7 40.0 0.31 0.330
1995 Bavaria XCL 12 6 1 8 9 1.51 36 25.00 22.2 36.1 1.14 1.312
1995 Bavaria AC 14 12 7 12 0.47 45 4.44 4.4 0.0 1.27 0.684
1995 Hollier ACSFD 40 74 78 73 0.45 265 4.53 7.9 0.0 2.15 0.912
1995 Pokela AFB 7 6 13 1 0.54 27 11.11 22.2 25.9 1.29 0.881
1996 Fehrenbacher AC 11 12 0.18 23 4.35 4.3 30.4 0.22 0.198
1996 Grabitz XCL 68 81 59 24 28 0.83 260 15.00 14.2 14.6 1.18 0.969
1996 Cambria EPIDC 25 12 25 9 0.17 71 2.82 9.9 8.5 1.07 0.492
1996 Acher-Wynn XCLSFDN 24 50 21 33 22 0.17 150 3.33 5.3 35.3 0.26 0.220
1996 Acher-Wynn XCL 10 17 8 13 19 0.94 67 17.91 16.4 53.7 0.61 0.747
1996 Griepp AC 18 6 7 15 92 1.04 138 7.97 18.1 9.4 2.87 1.866
1996 Griepp1 HCA 20 7 4 9 55 0.48 95 5.26 10.5 9.5 1.40 0.858
1996 Bachet HCA 11 27 5 0.65 43 20.93 37.2 4.7 2.75 1.277
1996 Harward XCL 2 7 7 13 1.36 29 10.34 17.2 0.0 6.11 2.642
1996 Mauney XCL 10 14 10 14 43 1.00 91 9.89 13.2 9.9 1.80 1.340
1997 Svennson AC 11 5 1.15 16 43.75 0.0 0.0 0.00 0.838
1997 Svennson ACSFD 13 4 0.36 17 11.76 0.0 0.0 0.00 0.261
ford type; HCA, hypothermic arrest; IR, intercostal reimplantation; SFD, spinal
m; XCL, clamp and sew.
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and 10% in most major clinical reports of thoracoabdomi-
nal aneurysms.28,29 Retrograde normothermic perfusion
with assisted circulation does not significantly reduce the
risk of renal failure, but rapid renal cooling with saline or
blood and profound hypothermia appear to offer signifi-
Fig 2. The mortality risk model uses the number of acute and
paralyzed patients to calculate a predicted mortality [predicted
mortality  (acute  paralyzed patients)  0.30]. The model
accounts for 76% of the variation in mortality between series.
Table I. Continued
Year Series Technique C1 C2 C3
1997 Jacob AC 14 12 3
1997 Okita HCA 8 4
1997 Cambria EPIDC 51 24 55
1997 Coselli XCL 254 209 120
1997 Safi ACSFD 104 118 28
1998 Svennson AC 24 9
1998 SAFI ACSFD 110 116 38
2000 Cambria EPIDC 53 30 66
2001 Kouchoukos HCA 34 37 25
2001 Coselli ACSFD 65 80
2002 Cambria EPIDC 92 59 120
2002 Kouchoukos HCASFD 37 45 32
2002 Coselli ACSFD 580 573 291
2003 Jacob ACSFD 68 95 25
2003 Safi ACSFD 213 205 133
2004 Coselli XCLSFD
2005 Jacob ACSFD 42 70
2006 Greipp ACSFD 41 13 8
2007 Cambria EPIDC 121 69 164
2007 Fehrenbacher HCASFD 27 49 20
2007 Coselli ACSFD 706 762 391
2007 Acher-Wynn XCLSFDN 92 153 94
2007 Acher-Wynn XCLSFDNIRP 25 20 8
2010 Acher-Wynn XCLSFDN 94 165 122
2010 Acher-Wynn XCLSFDNIRP 29 42 32
AC, Assisted circulation (atrial femoral or femoral-femoral bypass); C, Craw
fluid drainage; SFDN, SFD and naloxone; TA, descending thoracic aneuryscant renal protection.29-31Fig 3. A, There is a significant decline in cardiac index (func-
tion) with age, which may explain why age is a significant factor
for mortality and why cardiac index trumps age in a multivariate
model for paraplegia. B, Patients with reduced functional car-
diac capacity to respond to aortic clamp release (CI 3) had a
greater risk of death, and age was more important than cardiac
function in multivariate analysis, implying that age encompasses
other factors related to overall strength and vitality that affectC4 TA
Deficit
O/E
Pts
(No.)
Def
(%)
Mort
(%)
Acute
(%)
O/E
Mort
O/E
Morb
4 0.72 33 12.12 15.2 0.0 2.44 1.188
13 0.23 25 4.00 0.0 0.0 0.00 0.165
30 0.45 160 6.88 9.4 10.0 1.00 0.658
140 0 0.42 723 5.53 5.1 11.1 0.57 0.478
40 53 0.44 343 9.62 13.1 14.6 0.98 0.647
0.75 33 27.27 6.1 33.3 0.24 0.538
0.55 264 12.50 12.1 7.6 1.08 0.724
7 14 0.45 170 7.06 9.4 20.0 0.71 0.567
65 0.14 161 2.48 6.2 10.6 0.58 0.300
0.28 145 7.59 7.6 6.9 0.61 0.387
66 0.59 337 11.28 8.3 24.3 0.52 0.556
78 0.15 192 2.60 6.8 10.4 0.67 0.346
329 0.23 1773 4.46 7.7 11.6 0.68 0.401
0.14 188 2.66 10.6 3.7 1.23 0.472
194 160 0.21 905 3.98 15.8 12.0 1.36 0.642
387 0.50 387 2.58 4.4 12.9 0.66 0.586
0.22 112 4.46 13.4 4.5 1.44 0.595
6 32 0.12 100 2.00 6.0 10.0 0.62 0.312
101 0.71 455 12.97 8.6 20.0 0.60 0.661
14 63 0.18 173 2.31 4.0 8.1 0.52 0.307
427 0.22 2286 3.81 6.6 5.2 0.77 0.397
150 108 0.18 597 3.18 6.7 32.0 0.36 0.272
41 30 0.05 124 0.81 3.2 27.4 0.20 0.124
198 171 0.18 750 3.33 6.4 34.9 0.32 0.253
70 88 0.11 261 1.92 3.8 32.6 0.21 0.158survival.
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kidney with 300 to 400mL of cold renal perfusion solution
(lactated Ringer’s with 12.5 grams of mannitol and heparin
1000 Us/L at 4°C), which lowers the core temperature
and rapidly cools the kidney. With this protocol, 3.2% of
our patients required postoperative dialysis (66.7% in acute
patients), but only 0.8% required permanent dialysis, with
most patients recovering baseline renal function2 weeks.
In a multivariate model, acute presentation (odds ratio,
4.94; P  .0034) and preoperative estimated glomerular
filtration rate (odds ratio, 1.034/unit change; P  .0060)
were the most significant factors for dialysis. It is very clear
from our own and others’ data that rapid and profound
cooling of the kidney is the most effective protection from
renal failure and that most acute patients recover from
Fig 4. Renal function, a significant factor for mortality, declines
with age, but age and reduced renal function remain significant
independent factors for mortality.
Table II. Multivariate model for operative mortality
Variable Mortality Odds ratio P
Age, Y/N, yrs 74.98/66.35 1.0896 per yr .0001
Acute, Y/N, % 17.81/3.13 5.285 .0001
Paraplegia, Y/N, % 25.71/6.22 3.397 .0194
Pre-op creatinine,
Y/N, mg/dL
1.80/1.31 1.3906 per mg/dL .0289
Table III. Mortality by decade in 771 patients surgically
treated for thoracoabdominal and thoracic aortic
aneurysmsa
Age by decade No. Mortality, % elective Acute
60 153 0.0 1.56
60-70 244 1.78 14.67
70-80 311 4.00 24.27
80 70 5.13 41.94
aAcute patients were defined as having rupture, contained rupture, acute
dissection, mycotic aortitis, trauma, plaque, or intramural hemorrhage.transient renal failure.CONCLUSION
Despite the ordeal of open surgical repair of thoraco-
abdominal aneurysm, in modern reports, 82% of patients
Fig 5. Patients with reduced functional cardiac capacity to respond to
aortic clamprelease (CI3)hadagreater riskofparalysis, andcardiac index
was more important than age in multivariate analysis.
Fig 6. There are significant differences in paraplegia observed/ex-
pected (O/E) ratios within technique of repair but adhering to the
fundamental principles of spinal cord protection with protocols that
optimize control of spinal fluid pressure (SFD), hypothermia, cardiac
function, arterial perfusion pressure, andneurochemical protection result
in improved outcomes whether assisted circulation (AC), hypothermic
arrest (HCA), or clamp-and-sew (XCL) is the technique of repair.
Table IV. Paraplegia factorsa
Variable OR P
Crawford type 2 (Y) 12.45 .0001
SFDN (Y) 0.251 .0034
Cardiac index (per unit increase) 0.630 .0272
Acute (Y) 2.736 .0175
Dissection (Y) 4.567 .0012
OR, Odds ratio; SFD, spinal fluid drainage; SFDN, and naloxone.
aHigher cardiac index and use of our spinal cord protection protocol were
protective from paraplegia, whereas extent of replacement (Crawford type
C2), dissection, and acute presentation were associated with increased
paralysis risk.report the same or improved health status after surgery as
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reduced health status measures compared with a healthy
age-controlled population.32 Age80 years and complica-
tions such as renal failure and paraplegia compromise long-
term survival and functional recovery, leading to less than
optimal long-term results and quality of life, with only 20%
of patients surviving at 10 years.32,33 The increasing aware-
ness of the importance of quality of life—and not just
survival—should be a significant consideration when coun-
seling patients and making recommendations for treat-
ment.
Great strides in morbidity reduction have been made in
the surgical treatment of diseases of the thoracoabdominal
aorta, and the application of fundamental principles that
reduce the risk of themajor complications of paralysis, renal
failure, and death accounts for these improved results.
Advanced age with the associated decrease in renal, pulmo-
nary, and cardiac function, as well as quality of life mea-
sures, are factors that require more scrutiny and awareness
by patients and physicians when considering how to man-
age this complex group of aortic pathologies.
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